Abstract:Background: Piwi-interacting RNAs (piRNAs) are thought to silence transposable genetic elements. However, the functional roles of piRNAs in oral squamous cell carcinoma (OSCC) remain unelucidated. In the present study, we aimed to investigate the role of Piwi-interacting RNA 1037 (piR-1037) in chemoresistance to cisplatin (CDDP)-based chemotherapy and the oncogenic role of piR-1037 in OSCC cells. Methods: RT-PCR was used to evaluate the levels of piR-1037 and X-linked Inhibitor of apoptosis protein (XIAP) mRNA in OSCC cell lines or tumor xenografts. Transfection of piR-1037 DNA antisense and piR-1037 RNA oligonucleotides was performed to suppress and overexpress piR-1037 in OSCC cells, respectively. A CCK8 assay was used to measure the viability or proliferation of OSCC cells. Apoptosis in OSCC cells and xenografts was determined using a TUNEL assay kit. The activity of caspase-3, caspase-8 and caspase-1 in OSCC cells was measured with colorimetric caspase assay kits. Western blot analysis was conducted to analyze XIAP expression in OSCC cells and xenograft samples. Immunoprecipitation (IP) and RNA pull-down assays were utilized to analyze the piR-1037 - XIAP interaction. Transwell assays were performed to evaluate migration and invasion of OSCC cells. Results: CDDP treatment upregulated piR-1037 expression in OSCC cells and OSCC xenografts. Suppression of the CDDP-induced upregulation of piR-1037 expression enhanced the sensitivity of OSCC cells to CDDP. piR-1037 promoted protein expression and directly bound XIAP, a key apoptotic inhibitor that is implicated in chemoresistance. The relationship between piR-1037 and XIAP suggested that piR-1037 enhanced OSCC cell chemoresistance to CDDP at least partially through XIAP. Moreover, targeting the basal expression of piR-1037 inhibited cell motility by affecting epithelial-mesenchymal transition (EMT). Conclusion: piR-1037 enhances the chemoresistance and motility of OSCC cells. piR-1037 promotes chemoresistance by interacting with XIAP and regulates the motility of OSCC cells by driving EMT.

Pirna-31115 Promotes Cell Proliferation and Invasion Via PI3K/AKT Pathway in Clear Cell Renal Carcinoma

PIWI-Interacting RNA Pathway Genes: Potential Biomarkers for Clear Cell Renal Cell Carcinoma.

Comprehensive Profiling of Circrnas and the Tumor Suppressor Function of Circhipk3 in Clear Cell Renal Carcinoma

PIWI-interacting RNA 57125 Restrains Clear Cell Renal Cell Carcinoma Metastasis by Downregulating CCL3 Expression

Pir-651 Promotes Tumor Formation in Non-Small Cell Lung Carcinoma Through the Upregulation of Cyclin D1 and CDK4.

Role of Piwi-Interacting RNA-651 in the Carcinogenesis of Non-Small Cell Lung Cancer

Pir-001773 and Pir-017184 Promote Prostate Cancer Progression by Interacting with PCDH9.

Pirna-1742 Promotes Renal Cell Carcinoma Malignancy by Regulating USP8 Stability Through Binding to Hnrnpu and Thereby Inhibiting MUC12 Ubiquitination.

Piwi-interacting RNA-651 promotes cell proliferation and migration and inhibits apoptosis in breast cancer by facilitating DNMT1-mediated PTEN promoter methylation

Piwi-Interacting RNA1037 Enhances Chemoresistance and Motility in Human Oral Squamous Cell Carcinoma Cells

Novel Evidence for a PIWI-interacting RNA (pirna) As an Oncogenic Mediator of Disease Progression, and a Potential Prognostic Biomarker in Colorectal Cancer.

Novel Evidence for Oncogenic Pirna-823 As a Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer.

Pir-19166 Inhibits Migration and Metastasis Through CTTN/MMPs Pathway in Prostate Carcinoma

Knockdown of PIK3R6 impedes the onset and advancement of clear cell renal cell carcinoma

Identification and characterization of RASSF1C piRNA target genes in lung cancer cells

Pir-55490 Inhibits the Growth of Lung Carcinoma by Suppressing Mtor Signaling.

Novel Pirna MW557525 Regulates the Growth of Piwil2-iCSCs and Maintains Their Stem Cell Pluripotency.

PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3β/CTNNB1 signaling pathway

PIWIL1 interacting RNA piR-017724 inhibits proliferation, invasion, and migration, and inhibits the development of HCC by silencing PLIN3

Upregulated <i>circPDK1</i> Promotes RCC Cell Migration and Invasion by Regulating the <i>miR</i>-<i>377</i>-<i>3P</i>-<i>NOTCH1</i> Axis in Renal Cell Carcinoma

Clinical Value of Pir-36026 and Pir-651 in Esophageal Squamous Cell Carcinoma.